Transforming Population Health for Diabetes and Kidney Disease via Systems of Excellence
Am J Manag Care. 2025;31(Spec. No. 10):SP724_____Health care leaders and physicians from University Hospitals convened at an Institute for Value-Based...
Am J Manag Care. 2025;31(Spec. No. 10):SP724_____Health care leaders and physicians from University Hospitals convened at an Institute for Value-Based...
The Key Kidney Transplant Rejection Companies in the market include - Eledon Pharmaceuticals, Sanofi, Azurity Pharmaceuticals, Sanofi, Bristol Myers Squibb,...
The kidney transplant team at Oxford University Hospitals (OUH) has completed more than 5,000 adult kidney transplants since its first...
Voyxact gets accelerated approval, offering investors a new entrant in the high-value kidney disease market. The Food and Drug Administration...
Chronic kidney disease is increasingly affecting younger generations in Vietnam, reflecting a broader trend of early-onset chronic illnesses that threaten...
Demand for Autosomal Dominant Polycystic Kidney Disease Treatment in USA Forecast and Outlook (2025–2035) The demand for autosomal dominant polycystic...